Ian Barr

19.8k total citations · 3 hit papers
288 papers, 9.9k citations indexed

About

Ian Barr is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Ian Barr has authored 288 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 236 papers in Epidemiology, 73 papers in Infectious Diseases and 53 papers in Immunology. Recurrent topics in Ian Barr's work include Influenza Virus Research Studies (220 papers), Respiratory viral infections research (164 papers) and Animal Disease Management and Epidemiology (48 papers). Ian Barr is often cited by papers focused on Influenza Virus Research Studies (220 papers), Respiratory viral infections research (164 papers) and Animal Disease Management and Epidemiology (48 papers). Ian Barr collaborates with scholars based in Australia, Singapore and United States. Ian Barr's co-authors include Aeron C. Hurt, Anne Kelso, Karen Laurie, Yi‐Mo Deng, Naomi Komadina, Jessica K. Holien, Alan Hampson, Sheena G. Sullivan, Pina Iannello and Louise Carolan and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ian Barr

280 papers receiving 9.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution

2013 433 citations Björn F. Koel, David F. Burke et al. Science profile →
Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination

2022 144 citations Sheena G. Sullivan, Benjamin J. Cowling et al. Nature Communications profile →
Resurgence of avian influenza virus

2022 112 citations Michelle Wille, Ian Barr Science profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Ian Barr	7.1k	2.6k	1.8k	1.7k	1.4k	288	9.9k
John Steel	4.8k 0.7×	2.0k 0.8×	1.2k 0.7×	1.9k 1.1×	1.4k 1.0×	61	7.3k
Bruno Lina	6.2k 0.9×	4.3k 1.6×	1.9k 1.1×	1.0k 0.6×	613 0.4×	342	10.8k
William Barclay	5.8k 0.8×	5.5k 2.1×	3.0k 1.7×	3.2k 1.9×	1.3k 1.0×	213	12.1k
Sylvie van der Werf	4.4k 0.6×	3.9k 1.5×	2.3k 1.3×	1.2k 0.7×	1.2k 0.9×	206	9.1k
Anice C. Lowen	4.7k 0.7×	2.3k 0.9×	861 0.5×	1.1k 0.7×	1.6k 1.2×	95	6.8k
Emmie de Wit	5.0k 0.7×	8.6k 3.3×	1.7k 1.0×	1.6k 0.9×	1.7k 1.2×	105	13.3k
Adam Meijer	5.4k 0.8×	2.4k 0.9×	934 0.5×	734 0.4×	1.0k 0.7×	201	7.3k
Mel Krajden	8.4k 1.2×	3.5k 1.4×	871 0.5×	733 0.4×	514 0.4×	367	11.8k
Yong Poovorawan	8.2k 1.2×	6.0k 2.3×	1.8k 1.0×	980 0.6×	1.7k 1.3×	763	15.4k
Gaston De Serres	8.2k 1.2×	3.1k 1.2×	639 0.4×	990 0.6×	699 0.5×	299	10.5k

Countries citing papers authored by Ian Barr

Since Specialization

Citations

This map shows the geographic impact of Ian Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Barr more than expected).

Fields of papers citing papers by Ian Barr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Barr. The network helps show where Ian Barr may publish in the future.

Co-authorship network of co-authors of Ian Barr

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Barr. A scholar is included among the top collaborators of Ian Barr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Barr. Ian Barr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Barr, Ian, et al.. (2025). Laboratory biosafety risk assessment: A critical component of avian influenza preparedness. 7(1). 52–53.

Huddleston, John, Andrea N. Loes, S. Richard Turner, et al.. (2025). Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025. Virus Evolution. 11(1). veaf086–veaf086. 1 indexed citations

Lu, Cynthia, Ian Barr, Stephen Lambert, et al.. (2024). Developing a Research Network of Early Warning Systems for Infectious Diseases Transmission Between China and Australia. China CDC Weekly. 6(30). 740–753. 2 indexed citations

Mengersen, Kerrie, Ian Barr, Liping Wang, et al.. (2024). Towards development of functional climate-driven early warning systems for climate-sensitive infectious diseases: Statistical models and recommendations. Environmental Research. 249. 118568–118568. 14 indexed citations

Palomar, Daniel P., et al.. (2024). Seasonal antigenic prediction of influenza A H3N2 using machine learning. Nature Communications. 15(1). 3833–3833. 16 indexed citations

Aban, Malet, Michelle Wille, Natalie Spirason, et al.. (2024). Immune imprinting in early life shapes cross-reactivity to influenza B virus haemagglutinin. Nature Microbiology. 9(8). 2073–2083. 9 indexed citations

Bodle, Jesse, Kirsten Vandenberg, Karen Laurie, et al.. (2023). An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccines. Frontiers in Immunology. 14. 1147028–1147028. 4 indexed citations

Vanderven, Hillary A., Deborah Wentworth, Win Min Han, et al.. (2023). Understanding the treatment benefit of hyperimmune anti-influenza intravenous immunoglobulin (Flu-IVIG) for severe human influenza. JCI Insight. 8(14). 5 indexed citations

Mordant, Francesca L., Olivia Price, Rajeev Rudraraju, et al.. (2022). Antibody titres elicited by the 2018 seasonal inactivated influenza vaccine decline by 3 months post‐vaccination but persist for at least 6 months. Influenza and Other Respiratory Viruses. 17(1). e13072–e13072. 11 indexed citations

10.

Clarke, Michelle, Lynne Giles, Alexia Peña, et al.. (2022). A Prospective Study Investigating the Impact of Obesity on the Immune Response to the Quadrivalent Influenza Vaccine in Children and Adolescents. Vaccines. 10(5). 699–699. 9 indexed citations

11.

Mifsud, Edin, Steffen Wildum, Takao Shishido, et al.. (2022). Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model. Communications Biology. 5(1). 1026–1026. 7 indexed citations

12.

Goltsman, Daniela S. Aliaga, Lisa Alexander, Jyun‐Liang Lin, et al.. (2022). Compact Cas9d and HEARO enzymes for genome editing discovered from uncultivated microbes. Nature Communications. 13(1). 7602–7602. 20 indexed citations

13.

Sadarangani, Sapna P., Barnaby Edward Young, Hwee Pin Phua, et al.. (2022). DYNAMIC cohort study evaluating metabolic predictors of influenza vaccine immune response in older adults. npj Vaccines. 7(1). 135–135. 4 indexed citations

14.

McCauley, John W., et al.. (2021). The importance of influenza vaccination during the COVID‐19 pandemic. Influenza and Other Respiratory Viruses. 16(1). 3–6. 9 indexed citations

15.

Liu, Xiaoming, Thi Hiep Nguyen, Xiang Li, et al.. (2021). IL‐17A is a common and critical driver of impaired lung function and immunopathology induced by influenza virus, rhinovirus and respiratory syncytial virus. Respirology. 26(11). 1049–1059. 13 indexed citations

16.

Huddleston, John, John Barnes, Thomas Rowe, et al.. (2020). Integrating genotypes and phenotypes improves long-term forecasts of seasonal influenza A/H3N2 evolution. eLife. 9. 40 indexed citations

17.

Barr, Ian & Allen Cheng. (2018). Difficulties of predicting the timing, size and severity of influenza seasons. Respirology. 23(6). 562–563. 4 indexed citations

18.

Jennings, Lance, Q. Sue Huang, Ian Barr, et al.. (2017). Literature review of the epidemiology of influenza B disease in 15 countries in the Asia‐Pacific region. Influenza and Other Respiratory Viruses. 12(3). 383–411. 55 indexed citations

19.

Koel, Björn F., David F. Burke, Theo M. Bestebroer, et al.. (2013). Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution. Science. 342(6161). 976–979. 433 indexed citations breakdown →

20.

Guillonneau, Carole, Justine D. Mintern, Aeron C. Hurt, et al.. (2009). Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity. Proceedings of the National Academy of Sciences. 106(9). 3330–3335. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact